Uses of Tobraquine

Tobraquin is an antibiotic that inhibits protein synthesis in susceptible bacteria. Tobraquin is used to treat steroid-responsive inflammatory eye conditions. To ensure the effectiveness of use, users should follow the instructions of their doctors, and refer to the following article for more information about the uses of Tobraquine.

1.1. What is Tobraquine? Tobraquin eye drops are adjunctive therapy in the treatment of eye inflammation, or eye infection, and thermal or foreign body burns.
Tobraquin medicine has the main ingredients Tobramycin (in the form of Tobramycin sulfate) 15mg, Dexamethasone (in the form of Dexamethasone sodium phosphate) 5mg, and Excipients just enough 5ml.
Packing: box of 1 bottle with 5ml. Tobraquin is available in the form of a solution and eye drops. 1.2. What does Tobraquine do? Tobraquin is a prescription drug (ETC) that is used in cases where the patient has inflammation of the eye that has responded to corticosteroids, and is prescribed when there is a risk of superficial bacterial infection of the eye as follows:
Inflammatory disease blepharitis, conjunctivitis, and ocular inflammation. Chronic anterior uveitis. People with corneal damage caused by chemicals, radiation, thermal burns, or foreign bodies. Keratitis , and anterior segment of the eyeball. Contraindications:
Tobraquin should not be used in cases such as:
Patients with hypersensitivity to any ingredient, or excipients in the formula of the drug. Epithelial keratitis caused by herpes simplex, chickenpox, or cowpox, and other diseases caused by viruses. Eye infections caused by Mycobacterium. Eye disease caused by fungus. The case after surgery to remove the foreign body in the cornea has no complications.

2.1. How to use Tobraquin medicine Tobraquin medicine is a liquid medicine for eye drops Only need to shake well before using to instill. Absolutely when using, do not let the tip of the vial touch your eyes and do not share the vial with other people, to avoid infection. After instillation, the cap should be tightened. If the patient is using other eye drops, they should be instilled at least 5 minutes apart, and if the patient is using an ointment form, apply the eye drops later. together Wash hands and eyes thoroughly, then dry each time before instilling Tobraquin. Once symptoms improve, gradually reduce the number of drops. Do not stop taking the drug too soon. 2.2. Dosage of Tobraquin medicine According to the prescription of the specialist doctor. The recommended dosage is given as follows:
Apply 1 to 2 drops in the affected eye every 4 to 6 hours. During the first 2 days of dosing can be increased to 1 to 2 drops every 2 hours. Treatment when missed dose:
If the patient misses a dose of Tobraquin, it is necessary to add the dose of Tobraquin as soon as he remembers it. However, if it is too close to the next dose, skip the missed dose, and continue with the original scheduled dosing schedule. Do not take a double dose of Tobraquine to make up for a missed dose.
Treatment of overdose:
Overdose of Tobraquin eye drops is not considered dangerous. In the event of an emergency, or overdose with symptoms requiring emergency care, call 911 immediately, or go to the nearest local medical station. For timely diagnosis.

Using Tobraquin for a long time, there may be a fungal infection of the cornea. Long-term use of Tobraquin increases the risk of developing non-susceptible organisms. If superinfection is encountered, appropriate treatment should be instituted. Pregnant women, nursing mothers, and children should be careful before using. Avoid touching the dropper tip to the eye, or any surface to avoid contamination. Use in pregnant women, and nursing mothers
Pregnant women: Animal studies have shown that corticosteroids may have a teratogenic risk. Tobraquin can also cause congenital deafness in both ears, which is irreversible. Therefore, patients should only use it when the benefits of treatment outweigh the risks to the fetus.
Nursing mothers: Both active ingredients in Tobraquine can be excreted into breast milk in small amounts. Risk to children, patients should be careful when using, or consult a doctor before deciding to use the drug.
People who drive, and are operating machines
Side effects affect the ability to drive and use machines. Users need to be extra cautious when seeing side effects, in this case.

When using Tobraquin, patients may experience some unwanted side effects as follows:
Common:
Local toxicity in the eyes. Hypersensitivity causes itching, or eyelid edema, and conjunctival redness. Related to corticosteroids:
Glaucoma can develop into Glaucoma. Fungal infections of the cornea, especially with long-term steroid use. Secondary infection. Infrequent damage to the optic nerve. Slow healing of wounds. If the patient sees any unwanted side effects, please inform the doctor, or a qualified pharmacist for timely handling instructions.

When Tobraquin is used together with systemic antibiotics of the Aminoglycoside group, there will be increased nephrotoxicity, and ototoxicity. To ensure safety, and effectiveness, tell the specialist about all medications, or health foods that the patient is using for other eyes, and the eye disease the patient has. Drug Interactions Tobraquine can affect how the drug works, or cause side effects. Do not increase or decrease the dose of Tobraquin without consulting your doctor.

Store in sealed vials, in original packaging, with room temperature not exceeding 30 degrees Celsius. Avoid freezing, avoid direct light because high temperature can damage the ingredients in the medicine. Close the lid of the vial tightly when not in use. Keep out of reach of small children and household pets. Before taking Tobraquine should carefully check the expiry date of the drug. Absolutely do not use Tobraquin after the expiry date printed on the package. Once opened, the drug should not be used for more than 15 days. Above is important information about Tobraquine, patients should carefully read the instructions and consult a specialist doctor before using it to get the best treatment results.